摘要
甲状腺相关性眼病是临床上较为常见的一种眼病疾患,近年来,对其发病机制虽有较多研究,但并不明确,也正基于此情况,其治疗手段有限,疗效欠佳,给患者带来极大痛苦。本研究就目前国内外对甲状腺相关性眼病发病机制的报道进行分析,以期探索更为有效的新药开发,寻求更为安全的预防控制手段。
Thyroid - associated ophthalmopathy is a common type of ocular lesions. In recent years,there has been a lot of research on its pathogenesis, but the etiology and pathogenesis is not clear, so the treatment effect is not satisfied and that brought great suffering to the patients. In this paper,we analyzed the pathogenesis of thyroid - associated ophthalmopathy,in order to provide references for new drug discovery and effective control of the disease.
作者
李彦
李启富
Li Yan;Li Qifu(Department of Endocrinology,the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
出处
《中国基层医药》
CAS
2018年第10期1357-1360,共4页
Chinese Journal of Primary Medicine and Pharmacy
关键词
眼疾病
甲状腺
Eye disease
Thyroid gland